Molecules 2010, 15(3), 1690-1704; doi:10.3390/molecules15031690
Article

HTS-Driven Discovery of New Chemotypes with West Nile Virus Inhibitory Activity

Dong Hoon Chung 1,2,* email, Colleen B. Jonsson 1,2 email, Clinton Maddox 1 email, Sara N. McKellip 1 email, Blake. P. Moore 1 email, Marintha Heil 3 email, E. Lucile White 1 email, Subramaniam Ananthan 1 email, Qianjun Li 4 email, Shuang Feng 1 email and Lynn Rasmussen 1 email
1 Department of Biochemistry and Molecular Biology, Southern Research Institute, 2000 9th Ave S. Birmingham, AL 35205, USA 2 Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, Department of Microbiology and Immunology, 505. S. Hancock, University of Louisville, KY 40222, USA 3 Southern Research Institute, 431 Aviation Way, Frederick, MD 21701, USA 4 Division of Infectious Disease, 1900 University Boulevard, THT 229, University of Alabama at Birmingham, AL 35294, USA
* Author to whom correspondence should be addressed.
Received: 25 January 2010; in revised form: 20 February 2010 / Accepted: 8 March 2010 / Published: 12 March 2010
(This article belongs to the Special Issue High-throughput Screening)
PDF Full-text Download PDF Full-Text [697 KB, uploaded 13 March 2010 18:44 CET]
Abstract: West Nile virus (WNV) is a positive sense, single-stranded RNA virus that can cause illness in humans when transmitted via mosquito vectors. Unfortunately, no antivirals or vaccines are currently available, and therefore efficient and safe antivirals are urgently needed. We developed a high throughput screen to discover small molecule probes that inhibit virus infection of Vero E6 cells. A primary screen of a 13,001 compound library at a 10 µM final concentration was conducted using the 384-well format. Z′ values ranged from 0.54–0.83 with a median of 0.74. Average S/B was 17 and S/N for each plate ranged from 10.8 to 23.9. Twenty-six compounds showed a dose response in the HT screen and were further evaluated in a time of addition assay and in a titer reduction assay. Seven compounds showed potential as small molecule probes directed at WNV. The hit rate from the primary screen was 0.185% (24 compounds out of 13,001 compounds) and from the secondary screens was 0.053% (7 out of 13,001 compounds) respectively.
Keywords: West Nile virus; high throughput screen; antivirals; chemotypes

Article Statistics

Click here to load and display the download statistics.

Cite This Article

MDPI and ACS Style

Chung, D.H.; Jonsson, C.B.; Maddox, C.; McKellip, S.N.; Moore, B.P.; Heil, M.; White, E.L.; Ananthan, S.; Li, Q.; Feng, S.; Rasmussen, L. HTS-Driven Discovery of New Chemotypes with West Nile Virus Inhibitory Activity. Molecules 2010, 15, 1690-1704.

AMA Style

Chung DH, Jonsson CB, Maddox C, McKellip SN, Moore BP, Heil M, White EL, Ananthan S, Li Q, Feng S, Rasmussen L. HTS-Driven Discovery of New Chemotypes with West Nile Virus Inhibitory Activity. Molecules. 2010; 15(3):1690-1704.

Chicago/Turabian Style

Chung, Dong Hoon; Jonsson, Colleen B.; Maddox, Clinton; McKellip, Sara N.; Moore, Blake. P.; Heil, Marintha; White, E. Lucile; Ananthan, Subramaniam; Li, Qianjun; Feng, Shuang; Rasmussen, Lynn. 2010. "HTS-Driven Discovery of New Chemotypes with West Nile Virus Inhibitory Activity." Molecules 15, no. 3: 1690-1704.

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert